Valganciclovir
Links shared publicly online about this topic
Data Support Use of Lower Valganciclovir Doses - Renal and Urology News
renalandurologynews.com — “VANCOUVER, British Columbia"Half of the approved dose for cytomegalovirus (CMV) prophylaxis in solid organ transplant recipients is just as effective as the approved dose and is safer, new findings suggest.” View full resource at renalandurologynews.com
Most Recently Shared on November 2, 2010 at 5:51 pm By:
Renal Urology News Health News, Nephrology, Urology, and Medical Publisher
Data Support Use of Lower Valganciclovir Doses: VANCOUVER, British Columbia—Half of the approved dose for cytomega... http://bit.ly/blolPJ
FDA Alert: Valcyte (valganciclovir hydrochloride) Label Change: Possible overdose in pediatric patients
drugs.com — “FDA Alert: Valcyte (valganciclovir hydrochloride) Label Change: Possible overdose in pediatric patients” View full resource at drugs.com
Most Recently Shared on September 16, 2010 at 4:14 am By:
Drugs and Devices OW OW Health
Valcyte (valganciclovir hydrochloride) Label Change: Possible overdose in pediatric patients: Audience: Transp... http://bit.ly/cHgVyF #FDA
FDA Alert: Valcyte (valganciclovir hydrochloride) Label Change: Possible overdose in pediatric patients
drugs.com — “FDA Alert: Valcyte (valganciclovir hydrochloride) Label Change: Possible overdose in pediatric patients” View full resource at drugs.com
Most Recently Shared on September 17, 2010 at 1:21 am By:
FDA Alert - Labeling Change for Valcyte - Possible overdose in pediatric patients - http://bit.ly/9zTGIc
FDA Approves Valcyte (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
drugs.com — “Valcyte (valganciclovir hydrochloride) is used to prevent cytomegalovirus (CMV) disease in pediatric kidney and heart transplant patients. Includes Valcyte side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 31, 2009 at 8:32 pm By:
FDA Approves Valcyte to Prevent Cytomegalovirus (CMV) Disease in Pediatric Transplant Patients - http://bit.ly/6TUXY
FDA Approves Valcyte(R) (valganciclovir Hydrochloride) To Prevent Cytomegalovirus (CMV) Disease In Pediatric Patients
medicalnewstoday.com — “Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has approved Valcyte(R) (valganciclovir hydrochloride) for the prevention of cytomegalovirus (CMV) dis” View full resource at medicalnewstoday.com
Most Recently Shared on September 1, 2009 at 12:51 pm By:
MNT Pediatrics News Pediatrics and Health News
FDA Approves Valcyte(R) (valganciclovir Hydrochloride) To Prevent Cytomegalovirus (CMV) Disease In Pediatric Pat.. http://bit.ly/nE5KR
Infectious Dis. Medical News about Cytomegalovirus Infections Lung Transplantation Antibiotic Prophylaxis; Valganciclovir
mdlinx.com — “Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation” View full resource at mdlinx.com
Most Recently Shared on June 17, 2010 at 5:26 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Extended Valganciclovir Prophylaxis to Prevent Cytomegalovirus After Lung Transplantation: Annals of Internal M... http://bit.ly/dAD7vL #ID
FDA Approves Longer Valganciclovir CMV Prophylaxis for Kidney Transplant Patients - QualityPoint Technologies
qualitypointtech.net — “The FDA has approved an extended prophylactic dosing interval for valganciclovir HCl tablets in adult kidney transplant patients at high risk for cytomegalovirus disease. Medscape Medical News (Source: Medscape Today Headlines)” View full resource at qualitypointtech.net
Most Recently Shared on August 11, 2010 at 10:57 pm By:
FDA Approves Longer Valganciclovir CMV Prophylaxis for Kidney Transplant Patients: The FDA has approved an extende... http://bit.ly/bfiHbK
Post-Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosuppression - Lim - 2010 - American Journal of Transplantation - Wiley Online Library
onlinelibrary.wiley.com — “Post-Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosuppression - Lim - 2010 - American Journal of Transplantation - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on January 1, 2011 at 11:00 am By:
Urology & Nephrology OW Health
Postâ€*Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosup... http://bit.ly/dYHBpC
Post-Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosuppression - Lim - 2010 - American Journal of Transplantation - Wiley Online Library
onlinelibrary.wiley.com — “Post-Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosuppression - Lim - 2010 - American Journal of Transplantation - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on December 31, 2010 at 11:32 am By:
Postâ€*Liver Transplantation Multicentric Castleman Disease Treated with Valganciclovir and Weaning of Immunosup... http://bit.ly/e1R1jt
IMPACT Study Showed Longer Valcyte (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant
newswise.com — “New Phase III study results presented for the first time today at the ninth annual American Transplant Congress 2009 (ATC) demonstrate that doubling the duration of preventive therapy ("prophylaxis') with Valcyte (oral valganciclovir) significantly reduced the incidence of CMV disease by 56% in high-risk kidney transplant patients within the first year post-transplant.” View full resource at newswise.com
Most Recently Shared on June 1, 2009 at 7:54 pm By:
IMPACT Study Showed Longer Valcyte (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protecti.. http://bit.ly/A52by
Infectious Dis. Medical News about Cytomegalovirus
mdlinx.com — “Valganciclovir: Recent Progress” View full resource at mdlinx.com
Most Recently Shared on May 17, 2010 at 1:05 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Valganciclovir: Recent Progress: American Journal of Transplantation http://bit.ly/csK7UO #ID
Health Tip: Nap to Feel More Rested - Drugs.com MedNews
drugs.com — “Our careers and busy lifestyles are leaving many of us sleep deprived. The National Sleep Foundation says there s nothing wrong with a daily nap to help you fee” View full resource at drugs.com
Most Recently Shared on September 20, 2010 at 2:05 pm By:
Drugs and Devices OW OW Health
Health Tip: Nap to Feel More Rested: -- Our careers and busy lifestyles are leaving many of us sleep deprived... http://bit.ly/czSSUi #drug
FDA issues new dosing guide for children using Valcyte
fda.gov — “The U.S. Food and Drug Administration is notifying health care professionals of updated dosing recommendations for Valcyte (valganciclovir) oral tablets and solution used by children and adolescents receiving a kidney or heart transplant. The update is intended to prevent drug overdosing of children with low body weight, low body surface area, and very low serum creatinine. The revised dosing instructions now appear in the product's label.” View full resource at fda.gov
Most Recently Shared on September 15, 2010 at 5:56 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
FDA issues new dosing guide for children using Valcyte. http://ow.ly/2ELjC
Longer Antiviral Therapy Reduces Lung Transplant Complications - Drugs.com MedNews
drugs.com — “Extended antiviral treatment after a lung transplant may help prevent dangerous complications and organ rejection, a new study from Duke University Medical Cent” View full resource at drugs.com
Most Recently Shared on June 14, 2010 at 11:14 pm By:
Longer Antiviral Therapy Reduces Lung Transplant Complications - http://bit.ly/aose1y
Montana Gov Says Drug Companies Avoiding Taxes - Drugs.com MedNews
drugs.com — “From Associated Press (September 16, 2010) Montana Gov. Brian Schweitzer said new laws are needed to collect taxes on income that he says big drug companies are” View full resource at drugs.com
Most Recently Shared on September 16, 2010 at 7:38 pm By:
Drugs and Devices OW OW Health
Montana Gov Says Drug Companies Avoiding Taxes: From Associated Press (September 16, 2010) HELENA, Mont. -- ... http://bit.ly/dgT9H4 #drug
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Renal Urology News
Renal and Urology News reports on clinical news for both nephrologists and urologists.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Advertisement
